Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafenoquine versus primaquine with chloroquine for Plasmodium vivax malaria
RBR-48zmp6Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2016
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in malaria comparing Tafenoquine + chloroquine with Primaquine + chloroquine (2 arms). Primary endpoints: Incidence of hemolysis, Safety and 1 more. Started Jan 2016; status: completed.
02
Drugs
tafenoquineprimaquinechloroquine
03
Conditions
malaria
Beyond the preview
Go deeper on RBR-48zmp6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-48zmp6.